Tenet Healthcare Q2 2026 earnings beat
Analysis based on 6 articles · First reported Jul 15, 2026 · Last updated Jul 24, 2026
Tenet Healthcare's stock jumped over 20% as the earnings beat and raised guidance alleviated sector-wide fears about payer mix. The strong results are likely to boost investor confidence in the hospital sector and may lead to upward revisions of analyst price targets.
Tenet Healthcare reported second-quarter 2026 results that significantly exceeded analyst expectations. Adjusted EPS was $6.12 versus consensus of $4.26, and revenue of $5.63 billion beat the $5.43 billion forecast. The company raised its full-year 2026 guidance: EPS midpoint to $21.00 (well above prior consensus of $17.81) and revenue midpoint to $22.2 billion. Management attributed the outperformance to strong same-store revenue growth and expense discipline across Hospital Operations and Ambulatory Care segments. The results came after sector peer HCA Healthcare had cut its profit forecast due to a worsening payer mix, which had weighed on hospital stocks. Tenet's strong quarter decoupled it from that concern, and Moody's had recently upgraded Tenet's credit rating, reflecting debt reduction and cash generation. CEO Saum Sutaria highlighted operational execution and focus on higher acuity services. The stock surged over 20% on the news.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard